BR112013009577A2 - composição de gel tópico e método - Google Patents

composição de gel tópico e método

Info

Publication number
BR112013009577A2
BR112013009577A2 BR112013009577A BR112013009577A BR112013009577A2 BR 112013009577 A2 BR112013009577 A2 BR 112013009577A2 BR 112013009577 A BR112013009577 A BR 112013009577A BR 112013009577 A BR112013009577 A BR 112013009577A BR 112013009577 A2 BR112013009577 A2 BR 112013009577A2
Authority
BR
Brazil
Prior art keywords
gel composition
topical gel
topical
composition
gel
Prior art date
Application number
BR112013009577A
Other languages
English (en)
Inventor
Cyril Meunier
Jean-Christophe Buge
Kariine Nadau Fourcade
Original Assignee
Galderma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR1058611A external-priority patent/FR2966365B1/fr
Application filed by Galderma Sa filed Critical Galderma Sa
Publication of BR112013009577A2 publication Critical patent/BR112013009577A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
BR112013009577A 2010-10-21 2011-10-19 composição de gel tópico e método BR112013009577A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40538210P 2010-10-21 2010-10-21
FR1058611A FR2966365B1 (fr) 2010-10-21 2010-10-21 Composition de gel topique
PCT/EP2011/068261 WO2012052478A2 (en) 2010-10-21 2011-10-19 Topical gel composition

Publications (1)

Publication Number Publication Date
BR112013009577A2 true BR112013009577A2 (pt) 2016-07-12

Family

ID=45065557

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013009577A BR112013009577A2 (pt) 2010-10-21 2011-10-19 composição de gel tópico e método

Country Status (13)

Country Link
EP (1) EP2605753A2 (pt)
JP (1) JP2013540142A (pt)
KR (1) KR20130101552A (pt)
CN (1) CN103313700A (pt)
AU (1) AU2011317642A1 (pt)
BR (1) BR112013009577A2 (pt)
CA (1) CA2814975A1 (pt)
IL (1) IL225775A0 (pt)
MX (1) MX2013004472A (pt)
RU (1) RU2013123043A (pt)
SG (1) SG189338A1 (pt)
WO (1) WO2012052478A2 (pt)
ZA (1) ZA201302812B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2731606A1 (en) * 2011-07-14 2014-05-21 Allergan, Inc. Gel compositions of oxymetazoline and methods of use
CN104666239A (zh) * 2013-11-27 2015-06-03 杭州赛利药物研究所有限公司 酒石酸溴莫尼定凝胶及其制备方法
CN103919717A (zh) * 2014-04-15 2014-07-16 天津中医药大学 一种酒石酸溴莫尼定眼用凝胶制剂及其制备方法和用途
WO2018000067A1 (pt) * 2016-06-28 2018-01-04 Doris Maria Hexsel Uso de uma substância ativa no tratamento do melasma telangiectásico
WO2020222188A1 (en) 2019-05-01 2020-11-05 Clexio Biosciences Ltd. Methods of treating pruritus
CN110882211A (zh) * 2019-12-31 2020-03-17 深圳市瀚德标检生物工程有限公司 一种羟苯酯类凝胶剂及其制备方法
CN116159018A (zh) * 2023-03-01 2023-05-26 中国药科大学 一种新型外用溴莫尼定凝胶剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006A (en) * 1852-06-08 Improvement in seed-planters
US7439241B2 (en) * 2003-05-27 2008-10-21 Galderma Laboratories, Inc. Compounds, formulations, and methods for treating or preventing rosacea
US20050020600A1 (en) 2003-07-23 2005-01-27 Scherer Warren J. Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists
BRPI0511519A (pt) * 2004-05-25 2007-12-26 Sansrosa Pharmaceutical Dev In método para tratar ou prevenir um distúrbio inflamatório da pele e os sintomas associados com ele, composição tópica adequada para tratar ou evitar os sintomas de um distúrbio inflamatório dermatológico, e, embalagem para uma composição tópica
US20090061020A1 (en) * 2007-08-31 2009-03-05 Theobald Klaus P Brimonidine Compositions for Treating Erythema
PL2818184T3 (pl) 2007-11-16 2019-06-28 Aclaris Therapeutics, Inc. Kompozycje i sposoby do leczenia plamicy
CA2709199A1 (en) * 2007-12-21 2009-07-02 Galderma Laboratories, Inc. Pre-surgical treatment
JP5052558B2 (ja) * 2009-04-03 2012-10-17 ロート製薬株式会社 ゲル軟膏

Also Published As

Publication number Publication date
WO2012052478A3 (en) 2012-06-14
MX2013004472A (es) 2013-10-25
IL225775A0 (en) 2013-09-30
EP2605753A2 (en) 2013-06-26
RU2013123043A (ru) 2014-12-10
CN103313700A (zh) 2013-09-18
JP2013540142A (ja) 2013-10-31
ZA201302812B (en) 2014-06-25
SG189338A1 (en) 2013-05-31
WO2012052478A2 (en) 2012-04-26
AU2011317642A1 (en) 2013-05-02
CA2814975A1 (en) 2012-04-26
KR20130101552A (ko) 2013-09-13

Similar Documents

Publication Publication Date Title
BR112013010725A2 (pt) método, e, composição
BR112013011472A2 (pt) Composição de gel
BR112013016037A2 (pt) composição em gel.
BR112013007499A2 (pt) piridazinonas - métodos de criação e usos
BR112012017441A2 (pt) compostos e métodos
BR112013009578A2 (pt) composição tópica em gel e método
BR112013009489A2 (pt) aparelho e método de conexão
BR112012027159A2 (pt) estrutura e método
BR112013011340A2 (pt) géis e hidro géis
BR112014010450A2 (pt) composição e método
BR112014028282A2 (pt) composição cosmética anidra e método cosmético
BR112013013445A2 (pt) composição tópica promotora de melanina
BR112012027261A2 (pt) composição de shampoo condicionador
BR112013009577A2 (pt) composição de gel tópico e método
FR2957252B1 (fr) Composition cosmetique
BR112013014915A2 (pt) composição curativa e métodos de tratamento
BR112012023507A2 (pt) unidade de comutação e método relacionado
EP2555784A4 (en) GEL COMPOSITION ON HONEY BASE
FR2964937B1 (fr) Triporteur et direction de triporteur
FR2957787B1 (fr) Composition de maquillage
BR112013011743A2 (pt) dispositivo de redução de gel e método de redução de gel
BR112014010860A2 (pt) composição e método
BR112012029669A2 (pt) composição e método
BR112014009501A2 (pt) organogel e com´posição cosmética
BR112013014821A2 (pt) géis espalháveis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.